OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/26/2025
Back to search
Official data from USPTO
ANTENNOVA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
05/30/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
08/23/2023
Registration date
12/17/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
05/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Dover, DE
Examiner
KAPLAN, VALERIE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Antennova Inc
Antennova Therapeutics Inc.
Antengene Corporation Co., Ltd.
Representatives
Antennova Inc
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Human vaccine preparations; antibiotics for human use; biochemical drugsmixed biological preparations for the prevention and treatment of infectious diseases; pharmaceutical preparationsantivirals; pharmaceutical preparations for the treatment of cardiovascular diseases and disordersophthalmic diseases and disordersrespiratory diseases and disordershyperlipidemiahypertensionpulmonary hypertensiondiabetesinfectious diseaseshypercholesterolemiaallergiesinflammationpain; pharmaceutical preparationspharmaceutical products for the prevention and treatment of cancer; diagnostic preparations for medical purposes; dietetic foods adapted for medical purposes; enzymes for veterinary purposes; depuratives for the body; preparations for destroying noxious animals; medicated compresses; porcelain for dental prostheses
Publications
History of USPTO decisions and trademark events.
26 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/08/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/16/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/21/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
11/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/10/2024
PUBO
PUBLISHED FOR OPPOSITION
09/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/12/2024
CNRT
NON-FINAL ACTION MAILED
06/05/2024
CNRT
NON-FINAL ACTION WRITTEN
06/04/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
05/24/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/14/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/26/2024
DOCK
ASSIGNED TO EXAMINER
04/24/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
12/17/2023
MAFR
APPLICATION FILING RECEIPT MAILED
11/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/17/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/14/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/09/2023
Continuous trademark protection
Get notified about every new filing that threatens ANTENNOVA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.